Company performance
Add to research
Current Price
as of Feb 13, 2025$106.14
P/E Ratio
84.91
Market Cap
$156.43B
Description
Add to research
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. The MedSurg segment includes Endoscopy, Urology, and Neuromodulation. The Cardiovascular segment consists of Cardiology and Peripheral Interventions. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA.
Metrics
Add to research
Overview
- HQMarlborough, MA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerBSX
- Price$106.14+0.35%
Trading Information
- Market cap$156.43B
- Float99.54%
- Average Daily Volume (1m)6,474,155
- Average Daily Volume (3m)5,560,253
- EPS$1.26
Company
- Revenue$16.75B
- Rev growth (1yr)17.61%
- Net income$1.85B
- Gross margin68.61%
- EBITDA marginN/A
- EBITDAN/A
- EVN/A
- EV/RevenueN/A
- P/E84.91
- P/S9.42
- P/B7.55
- Debt/EquityN/A
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Factset